STAT+: Cepheid faces fresh criticism over the pricing of its TB diagnostics
STAT News
AUGUST 16, 2022
At issue is a TB test developed by Cepheid, which reached a 10-year deal with the WHO in August 2012 to supply its GeneXpert diagnostic to dozens of low- and middle-income countries. per cartridge, a reduction from the previous price tag of $16.86. In exchange for $11.1 Continue to STAT+ to read the full story…
Let's personalize your content